1,702
Views
23
CrossRef citations to date
0
Altmetric
Research Paper

Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients

, , , , , , , , , , , , , , , & show all
Pages 61-73 | Received 02 Dec 2015, Accepted 24 Dec 2015, Published online: 22 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ghada Barakat, Asser Elsharkawy & Yasmin Nabiel. (2021) Human leucocyte antigen – G gene polymorphism in laryngeal squamous cell carcinoma patients in Mansoura University Hospitals. Egyptian Journal of Basic and Applied Sciences 8:1, pages 214-221.
Read now
Laura S. Rozek, Shama Virani, Emily L. Bellile, Jeremy M. G. Taylor, Maureen A. Sartor, Katie R. Zarins, A. Virani, C. Cote, Francis P. Worden, Mark E. Prince Mark, Scott A. McLean, Sonya A. Duffy, George H. Yoo, Nabil F. Saba, Dong M. Shin, Omer Kucuk & Gregory T. Wolf. (2019) Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell Carcinoma. Nutrition and Cancer 71:5, pages 772-780.
Read now

Articles from other publishers (21)

Zhi Cui, Shiqun Sun, Jia Li, Jianing Li, Tong Sha, Jie He & Linjing Zuo. (2022) Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2). Current Cancer Drug Targets 22:9, pages 771-783.
Crossref
Di Zhang, Dan Zou, Yue Deng & Lihua Yang. (2021) Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing. Journal of Ovarian Research 14:1.
Crossref
Haoru Dong, Xinhua Shu, Qiang Xu, Chen Zhu, Andreas M. Kaufmann, Zhi-Ming Zheng, Andreas E. Albers & Xu Qian. (2021) Current Status of Human Papillomavirus-Related Head and Neck Cancer: From Viral Genome to Patient Care. Virologica Sinica 36:6, pages 1284-1302.
Crossref
Runmin Li, Guosheng Wang, ZhouJie Wu, HuaGuang Lu, Gen Li, Qi Sun & Ming Cai. (2021) Identification of 6 gene markers for survival prediction in osteosarcoma cases based on multi-omics analysis. Experimental Biology and Medicine 246:13, pages 1512-1523.
Crossref
S. Laban, M Brand, J. Ezić, J. Doescher, G. Völkel, H. A. Kestler, C. Brunner & T. K. Hoffmann. (2020) Tumorbiologie des OropharynxkarzinomsTumor biology of oropharyngeal carcinoma. HNO 69:4, pages 249-255.
Crossref
Nan Li, Kai Yu, Zhong Lin & Dingyuan Zeng. (2021) Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma. Combinatorial Chemistry & High Throughput Screening 24:2, pages 233-245.
Crossref
Yaojian Jin, Lan Wang, Hongqiang Lou, Chunhan Song, Xuying He & Mingxing Ding. (2021) Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer. Combinatorial Chemistry & High Throughput Screening 24:1, pages 98-108.
Crossref
Michaela Plath, Johanna Gass, Mario Hlevnjak, Qiaoli Li, Bohai Feng, Xavier Pastor Hostench, Matthias Bieg, Lea Schroeder, Dana Holzinger, Marc Zapatka, Kolja Freier, Wilko Weichert, Jochen Hess & Karim Zaoui. (2020) Unraveling most abundant mutational signatures in head and neck cancer. International Journal of Cancer 148:1, pages 115-127.
Crossref
Fujun Zhang, Yu Liu, Yixin Yang & Kai Yang. (2020) Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma. BMC Cancer 20:1.
Crossref
A. Dietz, G. Wichmann, T. Kuhnt & S. Wiegand. (2020) Organerhalt beim fortgeschrittenen Larynx‑/Hypopharynxkarzinom: Erfahrungen aus der DELOS-II-StudieOrgan preservation in advanced laryngeal/hypopharyngeal carcinoma: lessons from the DeLOS-II trial. HNO 68:9, pages 648-656.
Crossref
Kaifei Zhao, Lin Xu, Feng Li, Jin Ao, Guojun Jiang, Rongshu Shi, Fang Chen & Qing Luo. (2020) Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature. Bioscience Reports 40:8.
Crossref
HongLei Wang, Li Wu & HongTao Wang. (2020) Development and verification of a personalized immune prognostic feature in breast cancer. Experimental Biology and Medicine 245:14, pages 1242-1253.
Crossref
Stefan Schmidt, Annett Linge, Marianne Grosser, Fabian Lohaus, Volker Gudziol, Alexander Nowak, Ingeborg Tinhofer, Volker Budach, Ali Sak, Martin Stuschke, Panagiotis Balermpas, Claus Rödel, Henning Schäfer, Anca-Ligia Grosu, Amir Abdollahi, Jürgen Debus, Ute Ganswindt, Claus Belka, Steffi Pigorsch, Stephanie E. Combs, David Mönnich, Daniel Zips, Gustavo B. Baretton, Frank Buchholz, Michael Baumann, Mechthild Krause & Steffen Löck. (2020) Comparison of GeneChip, nCounter, and Real-Time PCR–Based Gene Expressions Predicting Locoregional Tumor Control after Primary and Postoperative Radiochemotherapy in Head and Neck Squamous Cell Carcinoma. The Journal of Molecular Diagnostics 22:6, pages 801-810.
Crossref
Feng Xue, Lixue Yang, Binghua Dai, Hui Xue, Lei Zhang, Ruiliang Ge & Yanfu Sun. (2020) Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma. PeerJ 8, pages e8301.
Crossref
Andreas Dietz, Susanne Wiegand, Thomas Kuhnt & Gunnar Wichmann. (2019) Laryngeal Preservation Approaches: Considerations for New Selection Criteria Based on the DeLOS-II Trial. Frontiers in Oncology 9.
Crossref
Jiabao Ma, Rui Li & Jie Wang. (2019) Characterization of a prognostic four‑gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma. Molecular Medicine Reports.
Crossref
S. Tribius, N. Würdemann, S. Laban, S. J. Sharma, S. Wagner, T. K. Hoffmann, C. Wittekindt & J. P. Klussmann. (2018) Update zu HPV-assoziierten Kopf-Hals-Karzinomen – Highlights der ASCO-Jahrestagung 2018Update on HPV-associated head and neck cancer—highlights of the 2018 ASCO Annual Meeting. HNO 66:12, pages 888-895.
Crossref
Gunnar Wichmann, Claudia Lehmann, Cindy Herchenhahn, Marlen Kolb, Mathias Hofer, Susanne Wiegand & Andreas Dietz. (2018) Development of a Human Leukocyte Antigen Score to Predict Progression-Free Survival in Head and Neck Squamous Cell Carcinoma Patients. Frontiers in Oncology 8.
Crossref
Diane Goltz, Heidrun Gevensleben, Joern Dietrich, Friederike Schroeck, Luka de Vos, Freya Droege, Glen Kristiansen, Andreas Schroeck, Jennifer Landsberg, Friedrich Bootz & Dimo Dietrich. (2017) PDCD1 ( PD-1 ) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients . Oncotarget 8:25, pages 41011-41020.
Crossref
Gunnar Wichmann, Anne Krüger, Andreas Boehm, Marlen Kolb, Mathias Hofer, Milos Fischer, Stefan Müller, Sandra Purz, Patrick Stumpp, Osama Sabri, Andreas Dietz & Regine Kluge. (2017) Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and 18F-FDG-PET/CT. European Journal of Cancer 72, pages 144-155.
Crossref
Maria Costales, Alejandro López‐Hernández, Cristina García‐Inclán, Blanca Vivanco, Fernando López, José Luis Llorente & Mario A. Hermsen. (2016) Gene Methylation Profiling in Sinonasal Adenocarcinoma and Squamous Cell Carcinoma. Otolaryngology–Head and Neck Surgery 155:5, pages 808-815.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.